NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI): M&A transaction — NeOnc acquires JandB Holdings for ~120k shares; Q2 net loss $5.68M; $50M partnership finalised

NEONC TECHNOLOGIES HOLDINGS, INC.

Acquired 100% of JandB Holdings for ~120k shares of common stock valued at $25 per share.
Q2 2025 net loss $5.68M ($0.30 per share) vs $4.52M ($0.27) in Q2 2024.
G&A expenses $984K, R&D $677K; both increased YoY due to trial expansion and partnership costs.
$50M strategic partnership with Quazar Investment finalised; GCC & MENA clinical trials platform to launch.
Director Ming-Fu Chiang resigned; Ishwar Puri elected to board effective August 18.

item 1.01 item 2.01 item 2.02 item 3.02 item 5.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

NEONC TECHNOLOGIES HOLDINGS, INC. completed an acquisition involving JandB Holdings, LLC for 120,000 shares of Company common stock with an attributed value of $25 per share (closed 2025-08-18).

Action: acquisition
Counterparty: JandB Holdings, LLC
Consideration: 120,000 shares of Company common stock with an attributed value of $25 per share
Closing: 2025-08-18

Exact text from the filing

to the Agreement, the Company acquired 100% of the issued and outstanding membership interests of JandB in exchange for an amount of shares of Company common stock equal to (a) 120,000 shares of Company common stock with an attributed value of $25 per share, less (b) an amount of shares equal to (x) the aggregate transaction fees incurred by the Company in

View on SEC.gov

30 m&a transactions filed in the last 30 days. Browse all m&a transactions →

NEONC TECHNOLOGIES HOLDINGS, INC. filing history →

Source: SEC EDGAR

accession 0001829126-25-006673

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.